Vidyalakshmi Chandramohan

Associate Professor in Neurosurgery
Vidyalakshmi Chandramohan
Vidyalakshmi Chandramohan

Overview

The research work in my laboratory focuses on identifying novel immunotherapeutic targets for the treatment of brain tumors, specifically glioblastoma (GBM). My previous work includes the development of the dual-specific immunotoxin (IT) D2C7-IT, which is currently in Phase I clinical trials in recurrent GBM (rGBM) patients. My current research seeks to identify novel strategies to enhance the efficacy of D2C7-IT and other GBM-targeted cytotoxic therapies. In conjunction with this, my research includes the investigation of immune-related biomarkers to predict the clinical outcome of D2C7-IT therapy in patients with GBM.

Positions

Associate Professor in Neurosurgery in the School of Medicine

2021 School of Medicine

Associate Professor in Pathology in the School of Medicine

2020 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2015 School of Medicine

Education

Ph.D. 2006

2006 Boston University

M.B.A. 2020

2020 North Carolina State University

Postdoctoral Associate, Surgery

2007 Duke University School of Medicine

Research Associate, Pathology

2010 Duke University School of Medicine

Research Associate, Sr, Pathology

2012 Duke University School of Medicine

Publications, Grants & Awards

Offices & Contact

185 MSRB
Durham, NC
27710
Box 3156 Med Ctr
Durham, NC
27710